BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15572279)

  • 1. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between neuroleptics and CYP2C6 in rat liver--in vitro and ex vivo study.
    Haduch A; Ogórka T; Boksa J; Daniel WA
    Pharmacol Rep; 2005; 57(6):872-7. PubMed ID: 16382211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic treatment with classic and newer antidepressants and neuroleptics on the activity and level of CYP2D in the rat brain.
    Haduch A; Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2004; 56(6):857-62. PubMed ID: 15662101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA; Syrek M; Ryłko Z; Kot M
    Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effects of neuroleptics on the activity of CYP2A in the liver of rats.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2005; 57(6):867-71. PubMed ID: 16382210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2007; 59(5):606-12. PubMed ID: 18048963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neuroleptics on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2011; 63(6):1491-9. PubMed ID: 22358097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
    Daniel WA; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
    Haduch A; Bromek E; Daniel WA
    Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2012; 64(6):1411-8. PubMed ID: 23406751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
    Daniel WA; Syrek M; Haduch A
    Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
    Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
    J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics.
    Daniel WA; Syrek M; Haduch A
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):371-7. PubMed ID: 12208554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
    Pekthong D; Martin H; Abadie C; Bonet A; Heyd B; Mantion G; Richert L
    J Ethnopharmacol; 2008 Feb; 115(3):432-40. PubMed ID: 18053665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.
    Daniel W
    Pol J Pharmacol Pharm; 1991; 43(3):197-206. PubMed ID: 1683700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carbamazepine on the pharmacokinetics of promazine.
    Syrek M; Wójcikowski J; Daniel W
    Pol J Pharmacol; 1996; 48(6):601-8. PubMed ID: 9112700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.